Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since. The Cell Saver autologous blood recovery systems are used in operating room procedures in which there is rapid bleeding or high-volume blood loss.
The Cell Saver 5 system offers:
The latest in microprocessor and sensor technologies
Full automation, with the option of switching to manual operation at any time
A compact, portable design, making it easy to transport
Advanced optics that assure consistent processing and a high-quality blood product
Bowl technology that provides fast processing and a consistent, high-quality blood product
Flexibility, with 225ml, 125ml, and 70ml bowls that expand processing options
Sequestering capabilities that enable semiautomatic collection of platelet-rich plasma
Built-in safety features that protect the patient's blood and the machine operator
Excellent service and support, from a company that recently won the Omega Northface Award for service excellence for the second year in a row
Indications for Use
Intraoperative Autotransfusion - Appropriate procedures include cardiac, vascular, orthopedic, pediatric, transplant, urologic and trauma surgery.
Preoperative Plasma and Platelet Sequestration
The Cell Saver 5 system is often used to sequester platelets and plasma from a patient immediately before surgery. The sequestered components are returned to the patient, if required, thereby reducing the need for allogeneic (donor) blood products and the inherent risks that are associated with donor blood.
Perioperative Platelet Sequestration
The enhanced sensor technology of the Cell Saver 5 system gives operators a consistent process for collection of Platelet-Rich Plasma ("PRP") with flexibility in producing ideal PRP volumes. PRP sequestered by the Cell Saver 5 system is often used to produce autologous platelet gel. It is well documented in scientific literature that platelets contain "growth factors" that have been shown to enhance wound healing and bone growth. However, the production and application of autologous platelet gel is considered a "practice of medicine." Therefore, Haemonetics cannot recommend or endorse specific procedures for production of platelet gel nor does it make any claims about the clinical efficacy of such procedures.